Efficacy of DZ1462, a Novel Sodium-phosphate Transporter Inhibitor, on 5/6 Nephrectomy-induced Hyperphosphatemia Model Rats

doi:10.12300/j.issn.1674-5817.2021.138

Abstract

Abstract:

Objective To study the efficacy of DZ1462, a novel sodium-phosphate transporter inhibitor, on rat hyperphosphatemia models established by 5/6 nephrectomy.Methods Totally 156 rats were randomly selected into four groups. Rats fed a normal diet were control group, named as group Ⅰ (n=6); rats fed a normal diet after 5/6 nephrectomy were named as group Ⅱ (n=60); rats fed a high phosphate diet after 5/6 nephrectomy were named as group Ⅲ (n=60); rats fed a high phosphate diet after sham surgery were named as group Ⅳ (n=30). The molding cycle was 10 weeks. Serum Pi was detected and the number of animal deaths was recorded every two weeks. Hematoxylin-eosin (HE) staining was performed to observe the change in kidney pathology, and to screen animal models with high phosphorus blood syndrome. Totally 18 model rats that met the inclusion criteria (all of group Ⅲ) were selected and randomly assigned to three groups: the model control group recorded as the G2 group; the DZ1462 administration group (30 mg/kg, tid, 21 d) recorded as the G3 group; the Sevelamer administration group (250 mg/kg, tid, 21 d) recorded as the G4 group. In addition, the normal control group was set as the G1 group. Serum phosphate levels were measured using a kit.Results In the 8^th and 10^th weeks, compared to group Ⅰ, serum phosphorus in group Ⅲ showed a significant difference (P < 0.01). The kidneys in group Ⅲ had obvious glomerular sclerosis, renal tubular atrophy, degeneration, interstitial inflammation, fibrosis, and calcification. Similarly to chronic kidney disease accompanied by hyperphosphatemia, the animal model was established successfully. At each time point, the serum phosphorus inhibition rate of the G3 group was significantly higher than that of the G4 group (P < 0.05).Conclusion DZ1462, as a novel small-molecule inhibitor of intestinal sodium and phosphorus transporter, can effectively inhibit intestinal phosphorus ion absorption in rat hyperphosphatemia model, and is expected to become a potential drug for the clinical treatment of hyperphosphatemia.

Key words: 5/6 Nephrectomy, Hyperphosphatemia, Sodium-phosphate transporter inhibitors, DZ1462, Rats

CLC Number:

Q95-33

Xiao LU,Lin ZHANG,Hui JI,et al. Efficacy of DZ1462, a Novel Sodium-phosphate Transporter Inhibitor, on 5/6 Nephrectomy-induced Hyperphosphatemia Model Rats[J]. Laboratory Animal and Comparative Medicine, 2022, 42(3): 187-193. DOI: 10.12300/j.issn.1674-5817.2021.138.

Figures/Tables 5

References 25

1	CHINYERE I R, MOUKABARY T, HUTCHINSON M D, et al. Progression of infarct-mediated arrhythmogenesis in a rodent model of heart failure[J]. Am J Physiol Heart Circ Physiol, 2021, 320(1): H108-H116. DOI:10.1152/ajpheart.00639. 2020 .
2	FOURNIER M L, CLÉMENT T, AUSSUDRE J, et al. Contusion rodent model of traumatic brain injury: controlled cortical impact[J]. Methods Mol Biol, 2021, 2193:49-65. DOI:10.1007/978-1-0716-0845-6_6 .
3	MARRA A. Animal models for drug development for MRSA[J]. Methods Mol Biol, 2020, 2069:253-266. DOI:10.1007/978-1-4939-9849-4_17 .
4	YOUNG F G. Growth and diabetes in normal animals treated with pituitary (anterior lobe) diabetogenic extract[J]. Biochem J, 1945, 39(5):515-536. DOI:10.1042/bj0390515 .
5	SARKAR D, AGRAWAL A, PAL D K. Clinical assessment of stabilisation of renal function after nephrectomy[J]. Urologia, 2021, 88(3):223-226. DOI:10.1177/0391560320987799 .
6	CHANTLER C, LIEBERMAN E, HOLLIDAY M A. A rat model for the study of growth failure in uremia[J]. Pediatr Res, 1974, 8(2):109-113. DOI:10.1203/00006450-197402000-00007 .
7	CZÉH B, SIMON M. Benefits of animal models to understand the pathophysiology of depressive disorders[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2021, 106:110049. DOI:10.1016/j.pnpbp.2020.110049 .
8	PÉREZ-LÓPEZ L, BORONAT M, MELIÁN C, et al. Animal models and renal biomarkers of diabetic nephropathy[J]. Adv Exp Med Biol, 2021, 1307:521-551. DOI:10.1007/5584_2020_527 .
9	MCCARRON A, PARSONS D, DONNELLEY M. Animal and cell culture models for cystic fibrosis: which model is right for your application? [J]. Am J Pathol, 2021, 191(2):228-242. DOI:10.1016/j.ajpath.2020.10.017 .
10	ROBINSON N B, KRIEGER K, KHAN F M, et al. The Current state of animal models in research: a review[J]. Int J Surg, 2019, 72:9-13. DOI:10.1016/j.ijsu.2019.10.015 .
11	GUO W, WANG L Y, HAN X, et al. Effect of parathyroid hormone on intestinal mucosal sodium dependent phosphorus transporter[J]. Iran J Kidney Dis, 2021, 1(1):48-55.
12	ASKARI H, SEIFI B, KADKHODAEE M. Evaluation of renal-hepatic functional indices and blood pressure based on the progress of time in a rat model of chronic kidney disease[J]. Nephrourol Mon, 2016, 8(3): e37840. DOI:10.5812/numonthly. 37840 .
13	LEVEY A S, STEVENS L A, CORESH J. Conceptual model of CKD: applications and implications[J]. Am J Kidney Dis, 2009, 53(3 ): S4-S16. DOI:10.1053/j.ajkd.2008.07.048 .
14	HAN Y, LU J S, XU Y, et al. Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling[J]. Int J Clin Exp Pathol, 2015, 8(5):4725-4734.
15	GHOSH S S, MASSEY H D, KRIEG R, et al. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation[J]. Am J Physiol Renal Physiol, 2009, 296(5): F1146-F1157. DOI:10.1152/ajprenal.90732.2008 .
16	JING W H, NUNES A C F, FARZANEH T, et al. Phosphate binder, ferric citrate, attenuates Anemia, renal dysfunction, oxidative stress, inflammation, and fibrosis in 5/6 nephrectomized CKD rats[J]. J Pharmacol Exp Ther, 2018, 367(1):129-137. DOI:10.1124/jpet.118.249961 .
17	王婷玉. 虫草保肾颗粒对5/6肾切除大鼠钙磷代谢的影响[D]. 哈尔滨: 黑龙江省中医药科学院, 2019.
	WANG T Y. Effect of Chongcao Baoshen Granules on calcium and phosphor metabolism with 5/6 nephrectomy rats[D]. Harbin: Heilongjiang College of Traditional Chinese Medicine, 2019.
18	BAO Y W, YUAN Y, CHEN J H, et al. Kidney disease models: tools to identify mechanisms and potential therapeutic targets[J]. Zool Res, 2018, 39(2):72-86. DOI:10.24272/j.issn.2095-8137.2017.055 .
19	RANI L, GAUTAM N K. Drosophila renal organ as a model for identification of targets and screening of potential therapeutic agents for diabetic nephropathy[J]. Curr Drug Targets, 2018, 19(16):1980-1990. DOI:10.2174/1389450119666180808114533 .
20	HAMZAOUI M, DJERADA Z, BRUNEL V, et al. 5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice[J]. Sci Rep, 2020, 10(1):1524. DOI:10.1038/s41598-020-58393-w .
21	李鑫宇, 李丹, 赵学智. 一步法5/6肾切除大鼠加高磷饮食快速建立肾衰竭致血管钙化动物模型法[J]. 中国中西医结合肾病杂志, 2010, 11(10):862-864, 后插二. DOI:10.3969/j.issn.1009-587X.2010.10.006 .
	LI X Y, LI D, ZHAO X Z. One-step approach of 5/6 nephrectomy plus high phosphorus diet to rapidly establish rat models of vessel calcification induced by renal failure[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2010, 11(10):862-864. DOI:10.3969/j.issn.1009-587X.2010.10.006 .
22	RADLOFF J, LATIC N, PFEIFFENBERGER U, et al. A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice[J]. Sci Rep, 2021, 11(1):14868. DOI:10.1038/s41598-021-94264-8 .
23	TSAO C W, HSU Y J, CHANG T C, et al. A high phosphorus diet impairs testicular function and spermatogenesis in male mice with chronic kidney disease[J]. Nutrients, 2020, 12(9):2624. DOI:10.3390/nu12092624 .
24	LARSSON T E, KAMEOKA C, NAKAJO I, et al. NPT-Ⅱb inhibition does not improve hyperphosphatemia in CKD[J]. Kidney Int Rep, 2017, 3(1):73-80. DOI:10.1016/j.ekir.2017.08.003 .
25	MARUYAMA S, MARBURY T C, CONNAIRE J, et al. NaPi-Ⅱb inhibition for hyperphosphatemia in CKD hemodialysis patients[J]. Kidney Int Rep, 2020, 6(3):675-684. DOI:10.1016/j.ekir.2020.12.017 .

分组 Group	动物数量 Animal n	第1周 1^st Week		第3周 3^rd Week		第5周 5^th Week		第7周 7^th Week		第10周 10^th Week
分组 Group	动物数量 Animal n	No.	Rd%	No.	Rd%	No.	Rd%	No.	Rd%	No.	Rd%
Ⅰ	6	0	0	0	0	0	0	0	0	0	0
Ⅱ	60	6	10	3	15	0	15	6	25	5	30
Ⅲ	60	8	13	2	16	2	20	2	23	10	40
Ⅳ	30	0	0	1	3	1	6	0	6	0	6

分组 Group	动物数量 Animal n	第1周 1^st Week		第3周 3^rd Week		第5周 5^th Week		第7周 7^th Week		第10周 10^th Week
分组 Group	动物数量 Animal n	No.	Rd%	No.	Rd%	No.	Rd%	No.	Rd%	No.	Rd%
Ⅰ	6	0	0	0	0	0	0	0	0	0	0
Ⅱ	60	6	10	3	15	0	15	6	25	5	30
Ⅲ	60	8	13	2	16	2	20	2	23	10	40
Ⅳ	30	0	0	1	3	1	6	0	6	0	6

[1]	TANG Jianping, ZHAO Liya, ZHAO Ying. Screening and Analysis of Microsatellite Genetic Markers in Commonly Used Inbred Rat Strains [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 388-396.
[2]	LI Jiafei, ZHANG Zhenhao, WANG Shuo, TIAN Ge, WEN Shuang, YAN Yuxue, CUI Ran, YE Zhen, CUI Yongchun. Effects of Autonomic Neuromodulators on Atrial Electrical Remodeling and Histopathological Changes in a Rat Model of Atrial Fibrillation [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 321-331.
[3]	AI Xiufeng, ZHANG Lizong, FANG Mingsun, LÜ Dongying, CHEN Chu, CAI Zhaowei, WANG Dejun. Analysis of Differences in the Intestinal Flora of Rats and Mice after Drinking Chlorinated Water Based on 16S rRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 437-445.
[4]	TANG Xiaohang, GU Yingmin, LÜ Yangyang, HUANG Mingshu, TIAN Xuesong. Evaluation of the Histological Staining Performance of Rat Eyeball Sections Prepared Using a Self-Developed Fixative [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 261-270.
[5]	SONG Jing, YANG Zongtong, LI Xiaojing, LI Zifa, SU Fengyun, XU Dongchuan, SUI Zaiyun. Effects of Xiebai San on the Morphological Structures of Lung and Intestinal Tissues and Expression Levels of PI3K and Akt in Rats with Allergic Asthma [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 191-204.
[6]	JIANG Haitao, YUAN Hantao, HUANG Wenting, YANG Rongrong, CHEN Xiaochun, YU Baoqing, LI Sibo. Regulation of Rat Intervertebral Disc Annulus Fibrosus Cell Proliferation and Apoptosis by Yaoshu Zhuyu Fang via miR-17-5P/MDM2/p53 Pathway [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 55-65.
[7]	LUO Yifan, ZHANG Zhenwei, MEI Lu, SHI Yeping, XING Yitong, ZHANG Zeqi, LI Chuxin, HAN Chunxia, YANG Pingshun, CHEN Qiusheng. Telocytes-Mediated Effects and Mechanisms of Anointing and Massage Therapy Using Oligopeptide-Herbal Medicine Composite Against Obesity in Rats [J]. Laboratory Animal and Comparative Medicine, 2025, 45(5): 551-560.
[8]	GAO Chaoqi, ZHU Zhibo, SUN Xiandong. Application Progress and Classification Analysis of Rat Vascular Remodeling Models [J]. Laboratory Animal and Comparative Medicine, 2025, 45(5): 542-550.
[9]	LIU Liyu, JI Bo, LIU Xiaoxuan, FANG Yang, ZHANG Ling, GUO Tingting, QUAN Ye, LI Hewen, LIU Yitian. Exploration of Rat Fetal Lung Tissue Fixation Methods [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 432-438.
[10]	QIN Chao, LI Shuangxing, ZHAO Tingting, JIANG Chenchen, ZHAO Jing, YANG Yanwei, LIN Zhi, WANG Sanlong, WEN Hairuo. Study on the 90-day Feeding Experimental Background Data of SD Rats for Drug Safety Evaluation [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 439-448.
[11]	LIU Zhiwei, YANG Ran, LIAN Hao, ZHANG Yu, JIN Lilun. Cartilage Protection and Anti-Inflammatory Effects of Fraxetin on Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 259-268.
[12]	JIANG Meng, HAO Shulan, TONG Liguo, ZHONG Qiming, GAO Zhenfei, WANG Yonghui, WANG Xixing, JI Haijie. Dynamic Evaluation of Vinorelbine-Induced Phlebitis of Dorsalis Pedis Vein in a Rat Model [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 251-258.
[13]	PAN Yicong, JIANG Wenhong, HU Ming, QIN Xiao. Optimization of Surgical Procedure and Efficacy Evaluation of Aortic Calcification Model in Rats with Chronic Kidney Disease [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 279-289.
[14]	LIAN Hui, JIANG Yanling, LIU Jia, ZHANG Yuli, XIE Wei, XUE Xiaoou, LI Jian. Construction and Evaluation of a Rat Model of Abnormal Uterine Bleeding [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 130-146.
[15]	YIN Yulian, MA Lina, TU Siyuan, CHEN Ling, YE Meina, CHEN Hongfeng. Establishment and Evaluation of a Rat Model of Non-Puerperal Mastitis [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 587-596.